Effect of anti-inflammatory agents on the glycosaminoglycan metabolism in cultured human synovial cells.
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001553:Benzbromarone / Q000031:analogs & derivatives / Q000494:pharmacology; D002478:Cells, Cultured; D003078:Colchicine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005343:Fibrinolytic Agents / Q000494:pharmacology; D005439:Flufenamic Acid / Q000494:pharmacology; D016670:Gabexate; D006025:Glycosaminoglycans / Q000378:metabolism* / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D007719:Knee Joint / Q000166:cytology; D008297:Male; D008954:Models, Biological; D011480:Protease Inhibitors / Q000494:pharmacology; D013583:Synovial Membrane / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans; D006146:Guanidines; D011480:Protease Inhibitors; C004528:benzarone; C013786:A73025; D001553:Benzbromarone; D016670:Gabexate; D005439:Flufenamic Acid; D003078:Colchicine